Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-22-000026 General Corporate
Debt relative to revenue 74th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.debt_to_revenue
109.21% · OPTIONAL · VALID
Capex intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
11.17% · OPTIONAL · VALID
Operating cash generation 40th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
8.37% · OPTIONAL · VALID
Revenue growth 29th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.revenue
15.42% · CORE · VALID
Inventory pressure 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
73.07% · OPTIONAL · VALID
Operating margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
6.90% · CORE · VALID
R&D intensity 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.94% · OPTIONAL · VALID
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.05% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 97.08%
Current 109.21%
Delta 12.13% Capex Intensity Increased
Previous 10.64%
Current 11.17%
Delta 0.53% Cash Generation Decreased
Previous 12.30%
Current 8.37%
Delta -3.93% Growth Decreased
Previous 22.12%
Current 15.42%
Delta -6.70% Inventory Pressure Increased
Previous 54.14%
Current 73.07%
Delta 18.93% Profitability Decreased
Previous 11.56%
Current 6.90%
Delta -4.66% R And D Intensity Increased
Previous 1.68%
Current 1.94%
Delta 0.27% Sbc Intensity Decreased
Previous 1.18%
Current 1.05%
Delta -0.13% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.